Singapore markets closed

Bayer Aktiengesellschaft (BAYN.DE)

XETRA - XETRA Delayed Price. Currency in EUR
Add to watchlist
30.76-0.35 (-1.13%)
As of 01:35PM CET. Market open.
Full screen
Previous close31.11
Open31.00
Bid30.75 x 28400
Ask30.77 x 2100
Day's range30.72 - 31.41
52-week range30.22 - 65.66
Volume1,642,807
Avg. volume3,528,012
Market cap30.219B
Beta (5Y monthly)0.99
PE ratio (TTM)N/A
EPS (TTM)-3.74
Earnings date08 Nov 2023
Forward dividend & yield2.40 (7.71%)
Ex-dividend date02 May 2023
1y target est51.20
  • Insider Monkey

    15 Countries that Produce the Most Genetically Modified Crops

    In this article, we will look into the 15 countries that produce the most genetically modified crops. If you want to skip our detailed analysis, you can go directly to the 5 Countries That Produce the Most Genetically Modified Crops. In the era of scientific innovation and development in practically every field, agriculture stands at […]

  • Financial Times

    Bayer chief blames thin drug pipeline on ‘years of under-investment’

    Bayer’s chief executive has blamed an “old chemistry mindset” and a chronic lack of investment in research by his predecessors for a thin drug pipeline that has dragged down the group’s share price. Bayer last week abandoned a trial of blood-thinner asundexian after it did not work as hoped to treat heart disease. The setback over a drug that was supposed to generate up to €5bn in annual sales at its peak caused Bayer’s already struggling stock to fall 18 per cent in a day.

  • Financial Times

    Bayer drug setback adds to new CEO’s problems

    Halted trial of prospective blockbuster treatment follows latest US legal blow over weedkiller Roundup